A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption

S. Altmann, Harry R. Davis, Li-Ji Zhu et al. · Science · 2004 · 1.8K citations

Dietary Cholesterol Consumption, Digestive Tract, Gastrointestinal Peptide Hormone +17

Bioanalytical Method Validation—A Revisit with a Decade of Progress

Vinod P. Shah, Kamal K. Midha, John W. A. Findlay et al. · Pharmaceutical Research · 2000 · 1.6K citations

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

Mikko Niemi, Elke Schaeffeler, Thomas Lang et al. · Pharmacogenetics · 2004 · 416 citations

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia

Robert H. Knopp · European Heart Journal · 2003 · 395 citations · Full text

Metabolic Syndrome, Primary Hypercholesterolemia, Non-pharmacological Intervention +10

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology · 2000 · 327 citations · Full text